Osteitis Fibrosa Cystica: Causes, Symptoms, and Treatment
What is Osteitis Fibrosa Cystica?
Osteitis fibrosa cystica is a skeletal disorder that occurs when the bones become soft, weak, and deformed due to excessive activity of the parathyroid glands, a condition known as hyperparathyroidism. This leads to the overproduction of parathyroid hormone (PTH), which disrupts the normal balance of calcium and phosphorus in the body. As a result, calcium is leached from the bones, making them prone to fractures, cysts, and fibrous tissue formation.
This condition is also referred to as von Recklinghausen disease of bone (not to be confused with neurofibromatosis, which is also called von Recklinghausen disease). It is a severe manifestation of hyperparathyroidism and requires prompt medical attention to prevent complications such as bone fractures, kidney stones, and other metabolic disturbances.
Common Causes
Osteitis fibrosa cystica is primarily caused by conditions that lead to elevated levels of parathyroid hormone (PTH). Below are the most common causes:
- Primary Hyperparathyroidism: This is the most common cause, often due to a benign tumor (adenoma) in one or more of the parathyroid glands. It can also result from hyperplasia (enlargement) of the glands or, rarely, parathyroid cancer (NIH).
- Secondary Hyperparathyroidism: This occurs when the parathyroid glands become overactive due to low calcium levels in the blood, often seen in chronic kidney disease (National Kidney Foundation).
- Tertiary Hyperparathyroidism: A condition where the parathyroid glands remain overactive even after the initial cause (such as kidney disease) has been treated, leading to autonomous PTH secretion.
- Chronic Kidney Disease (CKD): Impaired kidney function can lead to phosphate retention and decreased activation of vitamin D, both of which stimulate PTH secretion (CDC).
- Vitamin D Deficiency: Low levels of vitamin D reduce calcium absorption in the intestines, prompting the parathyroid glands to release more PTH to compensate (NIH).
- Malabsorption Syndromes: Conditions like celiac disease or Crohn’s disease can impair calcium and vitamin D absorption, leading to secondary hyperparathyroidism.
- Renal Tubular Acidosis: This kidney disorder affects the body’s acid-base balance and can contribute to bone demineralization and hyperparathyroidism.
- Long-term Lithium Use: Lithium, a medication used to treat bipolar disorder, can interfere with calcium metabolism and stimulate PTH release (NCBI).
- Familial Hypocalciuric Hypercalcemia (FHH): A rare genetic disorder that causes mild hypercalcemia and can lead to inappropriate PTH secretion.
- Parathyroid Carcinoma: Although rare, cancerous growths in the parathyroid glands can cause severe hyperparathyroidism and osteitis fibrosa cystica.
Associated Symptoms
Osteitis fibrosa cystica primarily affects the bones but can also lead to systemic symptoms due to disrupted calcium and phosphorus metabolism. Common symptoms include:
- Bone Pain and Tenderness: Often the first symptom, particularly in the legs, hips, and spine. The pain may worsen with movement or weight-bearing.
- Bone Deformities: Softening of the bones can lead to bowing of the legs, curvature of the spine (kyphosis), or other visible deformities.
- Pathological Fractures: Bones may fracture easily, even with minor trauma, due to weakened structure. Common sites include the ribs, hips, and vertebrae.
- Cystic Lesions: X-rays or imaging may reveal cystic areas within the bones, filled with fibrous tissue.
- Joint Pain and Stiffness: Due to calcium deposits in the joints (chondrocalcinosis) or secondary osteoarthritis.
- Muscle Weakness: High calcium levels (hypercalcemia) can cause muscle fatigue, weakness, or cramping.
- Kidney Stones: Excess calcium in the blood can lead to the formation of kidney stones, causing flank pain, bloody urine, or urinary tract infections.
- Gastrointestinal Symptoms: Hypercalcemia may cause nausea, vomiting, constipation, or abdominal pain.
- Neurological Symptoms: Severe hypercalcemia can lead to confusion, depression, memory loss, or even coma in extreme cases.
- Dental Issues: Loosening of teeth, jaw pain, or changes in bite alignment due to bone resorption in the jaw.
Symptoms may develop gradually, and some individuals may not experience noticeable symptoms until the condition is advanced. Regular monitoring is essential for those at risk, such as individuals with chronic kidney disease or a history of parathyroid disorders.
When to See a Doctor
It is important to seek medical attention if you experience any of the following:
- Persistent bone pain, especially if it worsens over time or is accompanied by swelling.
- Unexplained fractures, particularly in bones that are not typically prone to injury (e.g., ribs, spine).
- Visible deformities in the bones, such as bowing of the legs or curvature of the spine.
- Symptoms of hypercalcemia, including excessive thirst, frequent urination, nausea, vomiting, or confusion.
- Recurrent kidney stones or signs of kidney dysfunction.
- Muscle weakness or fatigue that interferes with daily activities.
- A family history of hyperparathyroidism or metabolic bone diseases.
Early diagnosis and treatment can prevent complications such as severe bone damage, kidney failure, or cardiovascular issues. If you have a known condition that increases your risk (e.g., chronic kidney disease), regular check-ups with your healthcare provider are crucial.
Diagnosis
Diagnosing osteitis fibrosa cystica involves a combination of clinical evaluation, laboratory tests, and imaging studies. Here’s how doctors typically approach the diagnosis:
Medical History and Physical Examination
Your doctor will begin by asking about your symptoms, medical history, and any risk factors (e.g., kidney disease, family history of parathyroid disorders). A physical exam may reveal bone tenderness, deformities, or signs of muscle weakness.
Laboratory Tests
- Serum Calcium Levels: Elevated calcium levels (hypercalcemia) are a key indicator of hyperparathyroidism.
- Parathyroid Hormone (PTH) Levels: High PTH levels confirm hyperparathyroidism. In primary hyperparathyroidism, PTH is inappropriately elevated despite high calcium levels.
- Phosphate Levels: Low phosphate levels are often seen due to increased urinary excretion caused by PTH.
- Vitamin D Levels: Low vitamin D can contribute to secondary hyperparathyroidism.
- Alkaline Phosphatase: Elevated levels may indicate increased bone turnover.
- Kidney Function Tests: Blood urea nitrogen (BUN) and creatinine levels help assess kidney function, which is often impaired in secondary hyperparathyroidism.
- Urinalysis: To check for excess calcium excretion or signs of kidney stones.
Imaging Studies
- X-rays: May reveal bone cysts, fractures, or deformities characteristic of osteitis fibrosa cystica. Classic findings include a "salt-and-pepper" appearance of the skull, subperiosteal bone resorption (especially in the fingers), and cystic lesions in long bones.
- Dual-Energy X-ray Absorptiometry (DEXA): Measures bone mineral density to assess osteoporosis or osteopenia.
- CT or MRI Scans: Provide detailed images of bone structure and can help identify cysts, tumors, or fractures.
- Ultrasound or Sestamibi Scan: Used to locate parathyroid adenomas or hyperplasia in the neck.
Bone Biopsy
In rare cases, a bone biopsy may be performed to confirm the presence of fibrous tissue and cysts within the bone. This is typically reserved for cases where the diagnosis is unclear.
Treatment Options
The primary goal of treatment is to address the underlying cause of hyperparathyroidism, restore normal calcium and phosphorus balance, and prevent further bone damage. Treatment options include:
Medical Treatments
- Surgery (Parathyroidectomy): The most definitive treatment for primary hyperparathyroidism involves the surgical removal of the overactive parathyroid gland(s). This is often curative and can reverse bone loss over time (Mayo Clinic).
- Medications for Hypercalcemia:
- Bisphosphonates: Drugs like alendronate or zoledronic acid help reduce bone resorption and lower calcium levels.
- Calcimimetics: Cinacalcet mimics calcium in the body, reducing PTH secretion. It is often used for secondary hyperparathyroidism in kidney disease.
- Denosumab: A monoclonal antibody that inhibits bone breakdown, used in cases where bisphosphonates are ineffective.
- Vitamin D and Calcium Supplements: Used cautiously in cases of secondary hyperparathyroidism due to vitamin D deficiency. However, these are avoided in primary hyperparathyroidism to prevent worsening hypercalcemia.
- Phosphate Binders: For individuals with kidney disease, medications like sevelamer or calcium acetate help reduce phosphate absorption and lower PTH levels.
- Hormone Replacement Therapy (HRT): In postmenopausal women, estrogen therapy may help reduce bone loss, though its use is carefully weighed against risks.
Management of Bone Complications
- Pain Management: Over-the-counter pain relievers (e.g., acetaminophen) or prescription medications (e.g., opioids for severe pain) may be used. Avoid NSAIDs if kidney function is impaired.
- Physical Therapy: Gentle exercises and physical therapy can help maintain muscle strength and mobility while minimizing fracture risk.
- Orthopedic Interventions: In cases of severe bone deformities or fractures, surgical interventions such as rod placement, joint replacement, or spinal stabilization may be necessary.
Lifestyle and Home Remedies
- Hydration: Drinking plenty of water helps prevent kidney stones by diluting urine and flushing out excess calcium.
- Dietary Adjustments:
- Avoid excessive calcium intake if you have primary hyperparathyroidism.
- Limit foods high in phosphorus (e.g., dairy, nuts, soda) if you have kidney disease.
- Consume a balanced diet rich in vitamins and minerals to support overall bone health.
- Fall Prevention: Use assistive devices (e.g., canes, walkers) if balance is affected, and modify your home to reduce fall risks (e.g., remove tripping hazards, install grab bars).
- Avoid Smoking and Alcohol: Both can weaken bones and interfere with treatment effectiveness.
Prevention Tips
While not all cases of osteitis fibrosa cystica can be prevented, the following strategies can help reduce your risk, especially if you have underlying conditions that predispose you to hyperparathyroidism:
- Manage Chronic Kidney Disease: Work closely with your healthcare team to monitor kidney function, control phosphate levels, and take prescribed medications (e.g., phosphate binders, vitamin D analogs).
- Monitor Calcium and Vitamin D Levels: Regular blood tests can help detect imbalances early, particularly if you have risk factors like malabsorption syndromes or a family history of parathyroid disorders.
- Adequate Vitamin D Intake: Ensure sufficient vitamin D through sunlight exposure, diet (fatty fish, fortified foods), or supplements if deficient. Aim for the recommended daily allowance (600–800 IU for most adults).
- Balanced Diet: Consume a diet rich in calcium (if appropriate for your condition), magnesium, and other bone-supporting nutrients. Avoid excessive phosphorus if you have kidney issues.
- Regular Exercise: Weight-bearing and resistance exercises help maintain bone density and muscle strength. Consult your doctor before starting a new exercise program.
- Avoid Long-term Lithium Use Without Monitoring: If you take lithium for bipolar disorder, regular PTH and calcium level checks are essential.
- Stay Hydrated: Drinking enough water supports kidney function and reduces the risk of kidney stones.
- Regular Health Check-ups: Routine screenings can help detect early signs of hyperparathyroidism or bone disorders, especially if you are at higher risk.
If you have a family history of parathyroid disorders or metabolic bone diseases, consider genetic counseling to assess your risk.
Emergency Warning Signs
Osteitis fibrosa cystica and hyperparathyroidism can lead to life-threatening complications if left untreated. Seek immediate medical attention if you experience any of the following:
- Severe Hypercalcemia Symptoms:
- Extreme confusion, delirium, or loss of consciousness.
- Severe nausea, vomiting, or abdominal pain.
- Irregular heartbeat, chest pain, or signs of a heart attack.
- Muscle twitching, seizures, or uncontrolled spasms.
- Signs of a Pathological Fracture:
- Sudden, severe pain in a bone after minor trauma or no trauma at all.
- Inability to bear weight on a limb or move a joint.
- Visible deformity or swelling at the site of a suspected fracture.
- Kidney Failure Symptoms:
- Little to no urine output.
- Swelling in the legs, ankles, or feet (edema).
- Shortness of breath due to fluid buildup in the lungs.
- Severe fatigue or confusion.
- Signs of Infection: If you have open wounds from bone deformities or fractures, watch for signs of infection such as fever, redness, warmth, or pus.
If you or someone else exhibits these symptoms, call emergency services or go to the nearest emergency room immediately. Severe hypercalcemia, in particular, is a medical emergency that requires urgent treatment to prevent coma or cardiac arrest.
Conclusion
Osteitis fibrosa cystica is a serious but treatable condition that arises from untreated hyperparathyroidism. Early diagnosis and intervention are key to preventing long-term complications such as bone deformities, fractures, and kidney damage. If you experience symptoms like bone pain, unexplained fractures, or signs of hypercalcemia, consult your healthcare provider promptly. With appropriate treatment—whether through surgery, medication, or lifestyle changes—many individuals can achieve significant improvement in bone health and overall well-being.